Crimson, a provider of data, analytics and business intelligence software to hospitals, was acquired by The Advisory Board Company, a provider of research, analysis and decision support tools to hospitals, health systems and biotech companies.
Crimson will continue all operations as a subsidiary of The Advisory Board Company and will leverage its resources to enhance its existing platform and develop new products.
Michael Kadyan, CEO of Crimson, said: The Advisory Board’s rock-solid operations, sales and support infrastructure and national member base will serve to expand our original vision at Crimson and enable us to further accelerate product development and services to customers.
